Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy

被引：0
|
作者：
Qianyu Zhu
Jialing Zhou
Hongyi Li
Hui Wang
Jiangbo Ren
Shujie Sun
Miaoran Yang
Shanshan Wu
Ming Cao
Kaixiang Wang
Hong You
Hong Ma
机构：
[1] Beijing Friendship Hospital,Liver Research Center
[2] Capital Medical University,Molecular Biology Laboratory
[3] National Clinical Research Center for Digestive Diseases,undefined
[4] Baoding People’s Hospital,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Biomarker; Hepatocellular carcinoma; Liver cirrhosis; Antiviral agent; Diagnosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12691 / 12701
页数：10
相关论文
共 50 条
  • [21] Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy
    Ghaly, Simon
    Gill, Raghubinder S.
    Keegan, Mathew J.
    Angus, Peter W.
    George, Jacob
    Nicoll, Amanda J.
    Law, Matthew
    Sinclair, Marie
    Lim, Lucy Y.
    Ratnayake, Hasanka
    Dunn, Anna
    Strasser, Simone I.
    Zekry, Amany
    HEPATOLOGY, 2012, 56 : 354A - 354A
  • [22] RISK FACTORS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B PATIENTS
    Chen, Junjie
    Feng, Tienan
    Zhang, Xinxin
    HEPATOLOGY, 2023, 78 : S491 - S492
  • [23] Dynamic Changes in Liver Stiffness in Patients with Chronic Hepatitis B Undergoing Antiviral Therapy
    Lazar, Alin
    Sporea, Ioan
    Popa, Alexandru
    Lupusoru, Raluca
    Gherhardt, Diana
    Mare, Ruxandra
    Apostu, Alexandru
    Hnatiuc, Madalina
    Sirli, Roxana
    DIAGNOSTICS, 2022, 12 (11)
  • [24] Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis
    Gao, Xuesong
    Yang, Hwai-, I
    Trinh, Huy
    Jeong, Donghak
    Li, Jiayi
    Zhang, Jian
    Le, An
    Hoang, Joseph
    Nguyen, Pauline
    Henry, Linda
    Nguyen, Mindie H.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (09) : 1207 - 1211
  • [25] THE RISK FACTORS OF DEVELOPING HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH ORAL ANTIVIRAL THERAPY AND INACTIVE STAGE DISEASE
    Cho, Y. K.
    Jung, G. M.
    Yun, S. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S341 - S341
  • [26] Does Antiviral Therapy for Chronic Hepatitis B Reduce the Risk of Hepatocellular Carcinoma?
    Abu-Amara, Mahmoud
    Feld, Jordan J.
    SEMINARS IN LIVER DISEASE, 2013, 33 (02) : 157 - 166
  • [27] Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?
    Thursz, Mark
    Brown, Ashley
    GUT, 2011, 60 (08) : 1025 - 1026
  • [28] Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma
    Wei, Qiang
    Xu, Xiao
    Ling, Qi
    Zhou, Bo
    Zheng, Shu-Sen
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2013, 12 (03) : 251 - 255
  • [29] Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?
    Warner, Nadia
    Locarnini, Stephen
    ANTIVIRAL THERAPY, 2009, 14 (02) : 139 - 142
  • [30] Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma
    Qiang Wei
    Xiao Xu
    Qi Ling
    Bo Zhou
    Shu-Sen Zheng
    Hepatobiliary & Pancreatic Diseases International, 2013, 12 (03) : 251 - 255
12345